After a lengthy period of stagnation, share prices across the space are rising once again. Our bet is that this is in anticipation of COMPASS Pathways’ Phase 2b data readout, expected in the coming weeks. We’re just polishing off a deep dive on that topic, replete with a Shakespeare-inspired pun (Hamlet, Act 3, Scene 1 – no prizes). This week we spoke to Rick Doblin, Executive Director of MAPS…


Previous articlePharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases
Next articlePreparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be?